# Sciobio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sciobio

- Industry: Biotechnology
- Headquarters: Chengdu, China
- Website: www.sciobio.com
- Latest round: Angel (Feb 29, 2020)
- Investors on record: 1

## About

Based in Chengdu, China and established in 2015, Sciobio is a provider of medical products and services such as reagents and consumables that provides medical supplies and medical instruments. In February 2020, the company closed a strategic investment from new investor Green Pine Capital Partners. 

Sciobio has a 3D-CC technology system and a 3D-STSAO intelligent manufacturing system, as well as technical platforms such as biotechnology, reagents and consumables, organ repair and medical device research and development. Products include cell and three-dimensional culture products, in vitro synthesis systems and polymer chromatography filler products. The products and technologies of the products can be used in the fields of nanomedicine, synthetic biology, drug development, protein field, cell engineering and tissue engineering.

The company generates revenue by offering medical products and services such as reagents and consumables.

## Funding rounds

- Angel, Feb 29, 2020 — Green Pine Capital Partners

## Investors

- Green Pine Capital Partners (https://capitalatlas.ai/funds/green-pine-capital-partners) — Angel